German
Sorafenib for Advanced and Refractory Desmoid Tumors
Overview of attention for article published in New England Journal of Medicine, December 2018
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (99th percentile)
-
Good Attention Score compared to outputs of the same age and source (75th percentile)
Mentioned by
- news
- 17 news outlets
- 112 X users
- 2 Facebook pages
- wikipedia
- 1 Wikipedia page
- googleplus
- 1 Google+ user
- 1 Redditor
- guideline
- 7 clinical guideline sources
- bluesky
- 1 Bluesky user
Readers on
- mendeley
- 279 Mendeley